AA Rewind 2017: Central Nervous System Rehabilitation

Member Price: $115.00

Nonmember Price: $205.00

Resident Price:$55.00

Nonmember Resident Price: $105.00

Release Date: December 2017

CME Expiration Date: December 31, 2020

NOTE: The Academy will not issue any refunds or exchanges for products purchased online. Purchased online activities are removed from "My Education (Mē)" after their expiration date. Please review the entire product description prior to purchase.

Tag(s) Focused Education, Central Nervous Systems Rehabilitation

Description

This product contains recorded sessions that took place during the Academy's Annual Assembly held in Denver, CO from October 12-15, 2017.

The following sessions are included in this product:

Expanding Access and Improving Outcomes for Spasticity Management Based on New Published Data

Gerald S. Bilsky, MD, FAAPMR (Session Director);Indira S. Lanig, MD, FAAPMR; Michael F. Saulino, MD, PhD,FAAPMR; Andrea P. Toomer, MD, FAAPMR; Joe Urquidez, MD,FAAPMR; Michael R. Yochelson, MD, FAAPMR

Using New Technology and Instruments to Assess the Level of Care in Patients Preparing to Enter the Post-Acute Care Setting

Matthew N. Bartels, MD, MPH, FAAPMR (Session Director);Matthew Palombelli, MHA

Getting Ahead of TBI Pain Syndromes

Jaime M. Levine, DO, FAAPMR (Session Director);Heidi N. Fusco, MD, FAAPMR; Kimberly A. Sackheim, DO, FAAPMR

Case-Based Discussion: Assessment and Treatment of Agitation After Traumatic Brain Injury

Cherry C. Junn, MD, FAAPMR (Session Director);Flora M. Hammond, MD, FAAPMR; Jeffrey J. Sherman, PhD;Travis J. Williams, DO; Jennifer M. Zumsteg, MD, FAAPMR

Advancing Concussion Management Through Innovative Technology

David M. Popoli, MD, FAAPMR (Session Director);Thomas G. Burns, PsyD; Sung Lee, MD; Kim Speake, BSN, RN, CPN;Jillian E. Urban, PhD

Too Sexsci! Sexual Intimacy and Fertility After SCI

David R. Gater, Jr., MD, PhD, MS, FAAPMR (Session Director);Lance L. Goetz, MD, FAAPMR; Kala M. Swope, MS, OTR/L

Ultrasound as an Extension of EMG/NCV

Shawn P. Jorgensen, MD, FAAPMR (Session Director);Andrea J. Boon, MD, FAAPMR; Michael C. Munin, MD, FAAPMR;Atul T. Patel, MD, MHSA, FAAPMR

Normal and Abnormal Gait Analysis: What Do We Need to Know as Physiatrists? Specific Clinical Applications for Runners and Patients with Lower Extremity Amputation

Ninad S. Karandikar, MBBS, FAAPMR (Session Director);Gary M. Berke, CP; Rebecca Dutton, MD, FAAPMR

Thriving Through Transformation: Sharpening Your Differential and Therapeutic Updates in Neuromuscular Diseases

Faye C. Chiou-Tan, MD, FAAPMR; Uvieoghene Ughwanogho, MD,FAAPMR (Session Directors); Pushpa Narayanaswami, MD

Arriving at the Optimal Orthotic Prescription

Alberto Esquenazi, MD, FAAPMR (Session Director)

Method of Study

Each session contains video presentations that were recorded during the Annual Assembly. Upon viewing the presentations, participants will need to complete a session evaluation, which includes a reflection on learning, in order to claim credit. The presentations can be viewed at one's own pace and credit can be claimed after viewing the individual sessions.

Accreditation Statement
The American Academy of Physical Medicine and Rehabilitation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation of Credit

The American Academy of Physical Medicine and Rehabilitation (AAPM&R) designates this enduring material for a maximum of 13.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Financial Disclosures
AAPM&R requires all individuals who are in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest, which is any entity producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. Disclosures are made in written form prior to the start of the educational activity and any potential conflicts of interest that exist are resolved prior to the start of the activity through AAPM&R’s Conflict of Interest Disclosure and Resolution Policy Process. Individuals in a position to control content and their disclosed financial relationships are listed below.

AAPM&R Medical Education Committee:

Steven R. Flanagan, MD, Chair: Disclosed no relevant financial relationships.
Anna-Christina Bevelaqua, MD: Disclosed no relevant financial relationships.
John C. Cianca, MD: Speaker’s Bureau for Advanced Health Education Center
Claire E. Finkel, MD: Disclosed no relevant financial relationships.
Rita G. Hamilton, DO: Disclosed no relevant financial relationships.
Mark E. Huang, MD: Cerner Corporation: Non-remunerative Positions of Influence; NU School of Physical Therapy: Honorarium
R. Sam Mayer, MD: Demos Publishing: Receipt of Royalties.
Andre Panagos, MD: Disclosed no relevant financial relationships.
Atul T. Patel, MD, MHSA: Speaker's Bureau for Allergan; has non-remunerative positions of influence with the AAOS Guideline Committee; and has participated on clinical trials for Ipsen, Merz, and Revance.
Amy Phelan, MD, DVM: Disclosed no relevant financial relationships.
Kerrie M. Reed, MD: Disclosed no relevant financial relationships.
Sunil Sabharwal, MD: Demos Publishing: Receipt of Royalties; American Board of Physical Medicine and Rehabilitation: Board of Directors
Nathaniel V. Zuziak, DO: Disclosed no relevant financial relationships.

AAPM&R CME Committee:

Kerrie M. Reed, MD, Chair: Disclosed no relevant financial relationships.
Rishi R. Bakshi, DO: Disclosed no relevant financial relationships.
Karen P. Barr, MD: Disclosed no relevant financial relationships.
John S. Harrell, MD: Disclosed no relevant financial relationships.
Didem Inanoglu, MD: Disclosed no relevant financial relationships.
Evan R. Peck, MD: Disclosed no relevant financial relationships.

No other planners, faculty or other individuals in control of content disclosed any relevant financial relationships.

FDA DisclosuresAll faculty members for this activity have disclosed they do not intend to discuss or demonstrate any pharmaceutical or medical device for which FDA clearance has not been approved.